Skip to main content
OpenTrials
Completed

NCT Number: NCT03440125

Cayenne Pepper Cataplasm - Safety Study

The beneficial analgesic effects of Rubefacenciae (redden skin substances), is known since 1830 as a treatment for pain, cramps, and disorders of the musculoskeletal system. Herbal cataplasms containing rubefacient substances, such as Cayenne pepper, are commonly used as natural medications to treat painful or aching areas in the case of acute or chronic back pain, and rheumatisms. In Vienna and lower Austria, a Cayenne Pepper Cataplasm (CPC) application containing Cayenne pepper and Kaolin powder in mixed proportion, is commonly used to treat musculoskeletal conditions of pain especially of the low back. However, a concern about the safety of such applications was recently raised.

Therefore, the aims of the present study are to evaluate the effects of 10x 20min CP cataplasm application as a single treatment or in combination with electrical stimulation and massage on selected functional and molecular parameters on i) healthy subjects and ii) subjects suffering from low back pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Facultiy of Physical Education and Sports, Comenius University of Bratislava, Bratislava, Slovakia

Loading trial locations.

About this study

Musculoskeletal diseases, such as neck and low back pain, are widespread disorders in many developed countries. Their management is challenging, and it may have mounting socioeconomic burden. Several evidences in the literature demonstrate the efficacy of many therapeutic strategies in the treatment of these conditions, based on pharmacological or surgical interventions. Physical medicine therapies are good alternatives that may have beneficial effects, especially when used as first line of intervention before approaching more expensive pharmacological or invasive medications. The beneficial analgesic effects of Applicatio Epispasticorum of Rubefacenciae (redden skin substances), is known since 1830 as a treatment for pain, cramps, and disorders of the musculoskeletal system. Herbal cataplasms containing rubefacient substances, such as Cayenne pepper (CP), are commonly used as natural medications to treat painful or aching areas in the case of acute or chronic back pain, and rheumatisms. They are also used in pain involving joints caused by osteoarthritis. A galenic preparation composed of rubefacient substances of vegetable origin, which generated vasodilation and increase in blood circulation on the treated areas, was first prescribed in 1909 by Dr. Giuseppe Munari to treat pain of various areas of the locomotive system. He proposed a method based on applications prepared according to his own galenic formula that have become famous all over Italy and Europe. In Vienna and lower Austria, a Munari-like application containing CP and Kaolin powder in mixed proportion, is commonly used to treat musculoskeletal conditions of pain especially of the low back. The research on responses to CPC applications, particularly in combination with other modalities is scarce.

Therefore, the aims of the present study are firstly to evaluate the effects of 10x 20min CP cataplasm application on selected functional and molecular parameters on healthy subjects. Then, the same applications will be used on subjects suffering from low back pain (LBP) - both as a single treatment and in combination with electrical stimulation and massage.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chronic low back pain (>3 months)
  • Body mass index below 35 kg/mˇ2

Exclusion criteria

  • pregnancy
  • sensibility disorders (e.g. due to neurological disease)
  • injuries, open wounds or rash in intervention area
  • known hypersensitivity against the applied substances
  • HIV, Hepatitis C and other due blood communicable infectious diseases

Treatment and study plan

Cayenne Pepper topical

Drug

20min topical Cayenne Pepper Cataplasm application containing 5% Cayenne Pepper nd 95% Kaolin mixed with water

Other names: Cayenne Pepper Cataplasm application

Electrical Stimulation

Device

Electrical stimulation 10min 60Hz biphasic rectangular neuromuscular electrical Stimulation (NMES)

Other names: Neuromuscular Electrical Stimulation (NMES)

Massage

Procedure

10 minutes of classical massage of low back pain area.

Other names: Classical massage

Primary outcomes

  1. Change in concentration of circulating biomarkers of inflammation, neudroendocrine stress and blood vessel activation

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    The blood analysis will include standard analysis of hemogram, C-reactive proteins, creatine-kinase, sedimentation, albumin and cortisol. Enzyme-linked immunosorbent assay (ELISA) will include Tumor necrosis factor-Alpha, Interleukin-6, Leukotriene B4 and P-Selectine. Additionally, microRNA analysis will be performed (gene numbers: 1, 21, 23, 25, 103, 126, 133, 146, 155, 199a, 199b, 191, 206, 451.

  2. Change in systolic and diastolic blood pressure

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    Systolic and diastolic blood pressure [mmHg], measured at both sides of the body with blood pressure gauge

  3. Heart rate

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    Heart rate (bpm), measured with heart rate monitor belt.

Secondary outcomes

  1. 36-Item Short Form Survey (SF-36)

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    The Short Form (36) Health Survey (SF-36) is a patient-reported survey of patient health. It consists of eight scaled scores, which are the weighted sums all questions in their respective section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the higher is the disability.

  2. Change in pain perception

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    Pain perception during rest and movement assessed with visual analogue scale (0-10). 0 represents no pain, and 10 represents severe pain.

  3. EQ-5D- 5L questionnaire

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    EQ-5D- 5L questionnaire includes following aspects: mobility, care, usual activities, pain/discomfort, anxiety/depression, crosswalk-index, self-feeling of health. Each aspect is evaluated on a 1-5 scale, with following descriptions of levels: having no problems, having slight problems, having moderate problems, having severe problems and being unable to do/having extreme problems. Visual analogue scale is the second part of the questionnaire, asking to mark health status on the day of the interview on a 20 cm vertical scale with end points of 0 and 100. There are notes at the both ends of the scale that the bottom rate (0) corresponds to " the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine".

  4. Oswestry disability index (ODI)

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    ODI will be used only in LBP arms (Arm 2 and 3). ODI is commonly used by clinicians and researchers to quantify disability for low back pain.

  5. Skin Sensory Function

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    Skin sensory function will be assessed by 2-point discrimination test (which is carried out using two pins, oriented in medial-lateral direction and pressed perpendicularly to the skin, with the medial pin being 3 cm laterally from the L3 spinal process. The subject is asked to report whether he/she felt one or two pins) and mono filament/light touch sensitivity tests (monofilaments calibrated to 0.025, 0.07, 2, 5, and 10 grams The subject is asked to report when he/she felt touching the skin with a monofilament 3 cm laterally from L3 spinal process). The lightest mono filament and the lowest pin inter-distance are take as final outcome measures.

  6. Flexibility

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    Assessment of total spine flexibility (forward bend test) and separately for the lumbar part (Schober's test) and thoracic part.

  7. Skin Temperature

    Time frame: Before the application, 45 minutes after 10th application and 48 hours after 10th application

    Skin temperature [°C] at the site of application (low back) and at the control part of the body (neck), measured with a laser thermometer.

Sponsors and collaborators

Lead sponsor

University of Primorska

Other

Collaborators

  • Comenius University
  • Ludwig Boltzmann Institute of Electrical Stimulation and Physical Rehabilitation
  • S2P, Science to Practice, Ltd.
  • Wilhelminenspital Vienna

Registry information

Official study title

Cayenne Pepper Cataplasm Application and Potential Side Effects

Acronym: Munari04

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Feb 20, 2018
Registry last updated
Feb 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.